| Literature DB >> 35589862 |
Aml S Ibrahim1, Nagah M Hafiz2, M F Saad2.
Abstract
Bacillus cereus is a common environmental foodborne microorganism that is mainly found to harbor toxigenic genes with multiple antibiotic resistances and is linked to threatening the safety of dried milk in concern to powdered infant milk formula. In the current investigation, the mean value of B. cereus in 140 samples of powdered milk was 0.57 × 102 ± 0.182 × 102, 0.15 × 102 ± 0.027 × 102, 0.21 × 102 ± 0.035 × 102, and 0.32 × 102 ± 0.072 × 102 CFU/g in a percentage of 64.0 samples of whole milk powder, 43.3 of skim milk powder, 26.7 of powdered infant milk formula and 36.7 milk-cereal-based infant formula, respectively. The results revealed that B. cereus isolates were found to harbor toxigenic genes in the following percentages: 77.8, 2.0, 72.7, 16.2, and 67.7 for nhe, hbl, cytK, ces, and bceT, respectively. Despite all evaluated B. cereus strains were originated from dairy powders, they showed a significant difference (P < 0.05) in their harbored toxigenic cytK gene between whole and skim milk powders with powdered infant formula and milk-cereal-based infant formula, as well as between powdered infant formula and milk-cereal-based infant formula. All isolated B. cereus strains were resistant to cefoxitin, colistin sulfate, neomycin, trimethoprim-sulfamethoxazole, oxacillin, and penicillin. Based on the antimicrobial resistance of B. cereus strains to cephalothin, chloramphenicol, nalidixic acid, and tetracycline, there was a significant difference (P < 0.05) between powdered infant milk formula and whole milk powder strains. This survey is one of few studies proceeded in Egypt to determine the prevalence of toxigenic B. cereus strains in milk-cereal-based infant formula and powdered infant formula as well as skim milk powder.Entities:
Keywords: Bacillus cereus; Milk–Cereal-based infant formula; Powdered infant milk formula; Powdered milk; Toxigenic genes
Mesh:
Substances:
Year: 2022 PMID: 35589862 PMCID: PMC9120150 DOI: 10.1007/s00203-022-02945-3
Source DB: PubMed Journal: Arch Microbiol ISSN: 0302-8933 Impact factor: 2.667
Statistical analytical results of count of B. cereus in the examined samples (CFU/g)
| Sample type | Positive samples | Min | Max | Mean ± S.E.M | |
|---|---|---|---|---|---|
| No | % | ||||
| Whole milk powder ( | 32 | 64.0 | 10 | 8.30 × 102 | 0.57 × 102 ± 0.182 × 102a |
| Skim milk powder ( | 13 | 43.3 | 10 | 0.40 × 102 | 0.15 × 102 ± 0.027 × 102b |
| Powdered infant milk formula ( | 8 | 26.7 | 10 | 0.30 × 102 | 0.21 × 102 ± 0.035 × 102c |
| Milk–cereal-based infant formula ( | 11 | 36.7 | 10 | 0.80 × 102 | 0.32 × 102 ± 0.072 × 102d |
n number of examined samples; No. number of positive samples; Min. minimum; Max. maximum; S.E.M. standard error mean
a, b and a, c superscript between rows indicates significant difference P < 0.05. a,d; b,c; c,d and b,d superscript between rows indicates non-significant difference P > 0.05
Fig. 1Distribution and differentiation of B. cereus group in the examined powdered milk sample. No. number of the examined isolates
Pattern of hemolytic and starch hydrolysis activities among B. cereus isolates obtained from the examined samples
| Type of samples | Hemolytic activity of | Starch hydrolysis of | ||||||
|---|---|---|---|---|---|---|---|---|
| Strong | Weak | Hydrolytic | Non-hydrolytic | |||||
| No | % | No | % | No | % | No | % | |
| Whole milk powder (No. = 54) | 49 | 90.7 | 5 | 9.3 | 35 | 64.8 | 19 | 35.2 |
| Skim milk powder (No. = 16) | 13 | 81.2 | 3 | 18.8 | 6 | 37.5 | 10 | 62.5 |
| Powdered infant milk formula (No. = 9) | 8 | 88.9 | 1 | 11.1 | 7 | 77.8 | 2 | 22.2 |
| Milk–cereal-based infant formula (No. = 20) | 19 | 95.0 | 1 | 5.0 | 20 | 100.0 | 0 | 0.0 |
| Total (No. = 99) | 89 | 89.9 | 10 | 10.1 | 68 | 68.7 | 31 | 31.3 |
No. number of the examined isolates
Prevalence of virulence enterotoxigenic genes of B. cereus isolated from the examined powdered milk samples
| Sample type | Confirmed | Virulence enterotoxigenic genes | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Whole milk powder (No. = 54) | 54 (100.0%) | 41a (75.9%) | 0a | 47a (87.0%) | 16b (29.6%) | 31a (57.4%) | 22 (40.7%) | 3 (5.6%) | 0 |
| Skim milk powder (No. = 16) | 16 (100.0%) | 16d (100.0%) | 0a | 12a (75.0%) | 0a | 14b (87.5%) | 10 (62.5%) | 0 | 0 |
Powdered infant milk formula (No. = 9) | 9 (100.0%) | 9a (100.0%) | 0a | 3b (33.3%) | 0d | 7d (77.8%) | 3 (33.3%) | 0 | 0 |
Milk–cereal-based infant formula (No. = 20) | 20 (100.0%) | 11e (55.0%) | 2a (10.0%) | 10c (50.0%) | 0a | 15d (75.0%) | 6 (30.0%) | 0 | 2 (10.0%) |
| Total | 99 (100.0%) | 77 (77.8%) | 2 (2.0%) | 72 (72.7%) | 16 (16.2%) | 67 (67.7%) | 41 (41.4%) | 3 (3.0%) | 2 (2.0%) |
No. number of the examined isolates
a,b; a,c; b,c and d,e in the same column indicate significant difference P < 0.05
a,a; a,d; a,e; b,d and d,d in the same column indicate non-significant difference P > 0.05
Fig. 2Relationship of hemolytic activity, starch hydrolysis and harboring genes nhe, hbl, cytK, ces, and bceT of B. cereus strains isolated from dried milk and infant formulas. No. number of the B. cereus strains
Antibiotics susceptibility evaluation of B. cereus strains
| Product | Whole milk powder (No. = 54) | Skim milk powder (No. = 16) | Powdered infant milk formula | Milk–cereal-based infant formula | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cefoxitin | 54a 100% | 0 | 0 | 16a 100% | 0 | 0 | 9a 100% | 0 | 0 | 20a 100% | 0 | 0 |
| Cephalothin | 54a 100% | 0 | 0 | 16ab 100% | 0 | 0 | 7b 77.8% | 0 | 2 22.2% | 20ab 100% | 0 | 0 |
| Chloramphenicol | 0a | 0 | 54 100% | 0a | 0 | 16 100% | 8b 88.9% | 1 11.1% | 0 | 0a | 0 | 20 100% |
| Colistin sulfate | 54a 100% | 0 | 0 | 16a 100% | 0 | 0 | 9a 100% | 0 | 0 | 20a 100% | 0 | 0 |
| Erythromycin | 16a 29.6% | 22 40.7% | 16 29.6% | 0b | 16 100% | 0 | 0ab | 9 100% | 0 | 5ab 25% | 0 | 15 75% |
| Gentamycin | 0a | 0 | 54 100% | 0a | 0 | 16 100% | 0a | 0 | 9 100% | 0a | 0 | 20 100% |
| Nalidixic acid | 0a | 0 | 54 100% | 0ab | 0 | 16 100% | 2b 22.2% | 2 22.2% | 5 55.6% | 9c 45% | 5 25% | 6 30% |
| Neomycin | 54a 100% | 0 | 0 | 16a 100% | 0 | 0 | 9a 100% | 0 | 0 | 20a 100% | 0 | 0 |
| Tetracycline | 0a | 0 | 54 100% | 0a | 0 | 16 100% | 8b 88.9% | 0 | 1 11.1% | 3b 15% | 0 | 17 85% |
| Tobramycin | 0a | 0 | 54 100% | 0a | 0 | 16 100% | 0a | 0 | 9 100% | 0a | 0 | 20 100% |
| Trimethoprim–sulfamethoxazole | 54a 100% | 0 | 0 | 16a 100% | 0 | 0 | 9a 100% | 0 | 0 | 20a 100% | 0 | 0 |
| Oxacillin | 54a 100% | 0 | 0 | 16a 100% | 0 | 0 | 9a 100% | 0 | 0 | 20a 100% | 0 | 0 |
| Penicillin | 54a 100% | 0 | 0 | 16a 100% | 0 | 0 | 9a 100% | 0 | 0 | 20a 100% | 0 | 0 |
| Streptomycin | 0a | 0 | 54 100% | 0a | 0 | 16 100% | 0a | 0 | 9 100% | 0a | 0 | 20 100% |
| Vancomycin | 0a | 0 | 54 100% | 0a | 0 | 16 100% | 0a | 0 | 9 100% | 0a | 0 | 20 100% |
No. number of the examined isolates, R resistant, I intermediate resistant, S susceptible
a,b; b,b; a,c; ab,c in the same row indicate significant difference P > 0.05
ab,b; ab,a; ab,ab; b,c in the same row indicate non-significant difference P < 0.05
Fig. 3Percentages of acceptability degree of the examined samples depend on Egyptian standards based on B. cereus count. n number of the examined samples; *Egyptian standards (ES: 1780/ 2014); **Egyptian standards (ES: 2072/2006); ***Egyptian standards (ES: 3284/2005)